Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

Long Term Experience of Mitral Valve Replacement

승모판치환수술의 장기 임상성적

  • 조용길 (인제대학교 부산백병원 흉부외과학교실) ;
  • 류지윤 (인제대학교 부산백병원 흉부외과학교실)
  • Published : 1996.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

Between Oct. 1985 and July 1995, 230 patients underwent mitral valve replacement. There were 77 men and 153 women whose mean age was 35.7 years, range 9 to 62 The concomitant operations were 40 aortic valve replacements(17.4%), 25 tricuspid annuloplasties(10.4%), 8 aortic valve replacements & tricuspid annuloplasties(3.5%), 2 tricuspid valve replacements(0.9%) and others, We used 139 mechanical (76 51. Jude medical, 33 CarboMedics, 30 Sorin) and 91 tissue 386 Carpentier-Edwards, 5 lonescu-Shiley) valves. The early postoperative complications occurred in 28 cases. There were 8 low cardiac output syndrome, 5 pleural effusion, 3 significant arrhythmia, 2 cardiac rupture and others. There were 6 early hospital deaths (2.6%) due to low cardiac output syndrome(2), arrhythmia(2) and ventricul r rupture(2). The cuAmulative notal follow-up period was 764. 4 patient-years with a mean of 4).9 months. The long term follow-up information was available for 212 patients(94.6%). There were 21 cases of valve-related complications. Prosthetic valve failure(10), anti-coagulation related bleeding (5), prosthetic valve endocarditis (4), and thromboembolism (2) occurred at rates of 1.3, 0.7, 0.5, and 0.3%Ipt-yr respectively. Late death occurred In 5 cases (0.7%/pt-yr) associated with prosthetic valve endocarditis (2), heart failure (2) and anti-coagulation related bleeding (1). There was no difference in the rate of freedom from prosthetic valve failure between the mechanical and tissue valve group at 6 years (100%), but there was significant difference at 9 years between the tissue (34.4%) and mechanical valve (100%) group (p=0.032). Actuarial survival rates were 98. 8% in tissue valve. 9).7% in mechanical valve group and 96.6% in total patients at 9 years.

1955년 9월 부터 1995년 7월까지 230례의 승모판치환수술이 시행되었다. 이 중 남자는 77명 여자가 153명이 었고 평균 연령은 35.7였다. 동반된 수술은 대동맥 판막치 환술(40례), 삼첨 판윤성 형술(25례), 대동맥판치환술+삼첨판성형술(8례),삼첨판치환술(2례)등이 있었다. 139례의 기계판막과 91개의 조직판막이 치환되었으며, 판막의 크기와 사용된 수는 31 mm(75개), 29mm(66개), 33mm(46개), 27mm(29개) 및 25mm(14개) 등이었다. 수술전 NYHA 기능적 등급은 II(76례), III(123례), IV(31례)였으며 술후 I(175례), II(49례) 등으로 호전되었다. 술후 조기 합병증은 28에서 발생하였으며 저심박출증씨 8례로 가장 많았다. 조기사망은 6례 (2.6%)였으며 사망원인은 저심박출증(2례), 부정맥(2례), 심장파열(2례) 등이 었다. 총 추적 기간 누계는 764.4 환자-년이었으며 평균추적 기간은 43.9개월이었다. 판막과 유관한 장기 합병증은 21례에서 발생하였으며 이중 판막파괴가 10례(1.3%1환자-년), 항응혈제 출혈 5례(0.7%/환자-년), 심내막염 4례(0.5%1환자-년) 혈색전증 2례(0.3%/환자-년) 등이었고 심장에 연유한 사망은 5례(0.7%/환자-년)에서 발생하였다. 9년 장기추적중 합병증 및 사망비발생률이 판막 상호간에 유의한 차가 없었으나 판막파괴비 발생률이 기계 판막(100%)과 조직 판막(34.4%) 사이에 유의한 차가 있었다(p=0.032). 9년간 보험통계적 생존률은 96.6%였다.

Keywords

References

  1. Selection of a prosthetic heart valve;Valvular heart disease: complehensive evaluation and managemant (1st ed) Cabanoglu,A.;Brockman,S.K.;Frankl,W.S.(ed.);Brest,A.N.(ed.)
  2. J Thorac Cardiovasc Surg v.40 Partial and complete prosthesis in aortic insufficiency Harken,D.E.;Soloff,H.S.;Taylor,W.J.
  3. Ann Surg v.154 Mitral ball valve prosthesis Starr,A.;Edwards,M.L.
  4. Scand J Thorac Cardiovasc Surg v.3 A new tilting disc valve prosthesis Bjork,V.O.
  5. J Thorac Cardiovasc Surg v.78 St. Jude Medical cardiac valve prosthesis in vitro studies Emery,R.W.;Nicoloff,D.M.
  6. 대흉외지 v.26 CarboMedics 기계판막의 임상경험 김기출;채헌;안혁
  7. 대흉외지 v.25 St. Jude Medical판을 이용한 심판막치환술의 성적 조광현;황윤호;이양행;정신현;최강주
  8. 대흉외지 v.25 승모판막치환후의 조기및 장기추적결과 김명인;황석화;유웅철(등)
  9. 대흉외지 v.27 심장 다판 치환술의 임상성적 김상형;김주홍;나국주
  10. 대흉외지 v.27 소아심장판막 치환술 김혁;유재현;서필원(등)
  11. 대흉외지 v.27 심장판막치환술의 임상적 고찰 강창희;은증화;남충희;이길노
  12. Acquired disease of the mitral valve;Surgery of the chest(6th ed.) Spencer,F.C.;Galloway,A.C.;Colvin,S.B.;Sabiston,D.C.(ed.);Spencer,F.C.(ed.)
  13. Ann Thorac Surg v.44 Thrombolytic and bleeding complications of prosthetic heart valve : Collective review Edmund,L.H.
  14. Ann Thorac Surg v.47 A comparision of mitral valve reconstruction with mitral valve replacement : Intermediate-term results Galloway,A.C.;Colvin,S.B.;Baumann,F.G.
  15. Mitral valve replacement with SJM prosthesis;Cardiac valve replacement current status (1st ed.) Doupon,H.;Michaud,J.L.;Duveau,D.(et al.);Matloff,J.M.(ed.)
  16. Circulation v.76 no.SUP. Ⅲ Long term performance of the St. Jude Medical valve : low incidence of thromboembolism and hemorrhugic complications with modest doses of warfarin Kopf,G.S.;Hammond,G.L.;Geha,A.(et al.)
  17. Ann Surg v.203 Experience with 1643 porcine prosthesis valves in 1492 patients Spencer,F.C.;Grossi,E.A.;Baumann,F.G.(et al.)
  18. Ann Thorac Surg v.46 Carpentier-Edward's standard porcine bioprosthesis : primary tissue failure by age groups Jamieson,W.R.;Rosado,L.J.;Munro,A.I.(et al.)
  19. Ann Thorac Surg v.43 St. Jude Medical prosthesis : valve related death and complications Arom,K.V.;Nicoloff,D.M.;Kersten,T.E.(et al.)
  20. Ann Thorac Surg v.24 Patient related risk factors as predictors of results following isolated mitral valve replacement Salmon,N.W.;Stison,E.B.;Griepp,R.B.(et al.)